Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 25 per...
Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $3.25 to $...
https://x.com/POTUS/status/1813565568454127970
Alliance Global Partners analyst James Molloy initiates coverage on IGC Pharma (AMEX:IGC) with a Buy rating and announces Pr...
https://www.marijuanamoment.net/gop-congressional-committee-approves-bill-to-block-marijuana-rescheduling-while-rejecting-state...
- Preliminary Analysis confirms the presence of TGR-63 in brain tissue and shows no adverse effects. -IGC Pharma, Inc. (NYSE:IG...
https://www.marijuanamoment.net/california-legislature-approves-bill-to-break-psychedelics-research-logjam-sending-it-to-governor/
